4
4D MOLECULAR THERAPEUTICS INC
NASDAQ: FDMT (4D Molecular Therapeutics, Inc.)
Kemas kini terakhir: 2 jam lalu11.90
-0.88 (-6.89%)
| Penutupan Terdahulu | 12.78 |
| Jumlah Dagangan | 683,476 |
| Harga / Jualan (P/S) | 8.97 |
| Harga / Buku (P/B) | 1.73 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -383,007.15% |
| EPS Cair (TTM) | -3.18 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -50.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.08% |
| Nisbah Semasa (MRQ) | 12.36 |
| Aliran Tunai Operasi (OCF TTM) | -153.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -90.21 M |
| Pulangan Atas Aset (ROA TTM) | -22.18% |
| Pulangan Atas Ekuiti (ROE TTM) | -32.97% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | 4D Molecular Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 0.0 |
| Persekitaran Makro | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.77 |
|
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector). |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.88% |
| % Dimiliki oleh Institusi | 95.91% |
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |